Registering patients on peritoneal dialysis in China
Official title: Peritoneal Dialysis Registration System (PERSIST)
Run by Sun Yat-sen University · NCT02989298 · Data updated 2026-11-12
This study is trying to gather information from patients on peritoneal dialysis in China to see how they are doing and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | December 2013 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT02989298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with end-stage renal disease who are currently receiving peritoneal dialysis.
✕Probably not a fit
Patients who are not receiving peritoneal dialysis or those with acute renal failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves the registration of all patients undergoing peritoneal dialysis (PD) for end-stage renal disease (ESRD) at selected hospitals in China. It aims to develop a comprehensive database that collects demographic and clinical data, including patient characteristics, treatment details, and quality of life metrics. Patients will be followed up every three months to monitor various clinical outcomes such as survival rates, complications, and changes in kidney function. The collected data will be analyzed to improve understanding of PD outcomes and patient care.
Why it matters
Potential benefit: If successful, this study could enhance the management and outcomes of patients undergoing peritoneal dialysis.
How similar studies have gone: Other studies have shown success in using registries to improve patient outcomes in dialysis, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:PD patients - Exclusion Criteria:No \-
Where it's running
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Xueqing Yu, M.D. & Ph.D. — First Affiliated Hospital, Sun Yat-Sen University
- Study coordinator: Xueqing Yu, M.D. & Ph.D.
- Email: yuxq@mail.sysu.edu.cn
- Phone: 8620-87766335
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Canagliflozin to improve ultrafiltration and reduce peritoneal fibrosis in people on peritoneal dialysis
We will test whether taking canagliflozin reduces glucose absorption by the peritoneal membrane and improves ultrafiltration in people on peritoneal dialysis.
-
Daily ergothioneine supplementation for people with kidney failure on dialysis
This trial tests whether a daily ergothioneine pill can restore blood ergothioneine levels in people with kidney failure who receive dialysis.
-
Adding urea to the final dialysis fluid
This test tries adding urea to the dialysis fluid for adults with advanced kidney failure who have very high blood urea and need rapid lowering of potassium or correction of severe acidosis.
-
SelfWrap-Assisted Arteriovenous Fistulas for Chronic Kidney Disease
This study is testing if a new wrap called SelfWrap can make it safer and more effective for people with chronic kidney disease to have a new arteriovenous fistula created.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.